Matthew J Jones
Overview
Explore the profile of Matthew J Jones including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harrisson K, Beheregaray L, Bice C, Booth E, Brauer C, Butler G, et al.
Mol Ecol
. 2025 Mar;
:e17714.
PMID: 40040486
Freshwater ecosystems and their biota are under increasing pressure from anthropogenic stressors. In response to declining fish stocks, hatchery and stocking programmes are widely implemented as core components of restoration...
2.
Dutra H, Marshall D, Comerford B, McNulty B, Diaz A, Jones M, et al.
PLoS Negl Trop Dis
. 2024 Sep;
18(9):e0012482.
PMID: 39255310
Background: Climate change and urbanization will alter the global distribution of disease vectors, changing the disease burden in yet unpredictable ways. Aedes aegypti is a mosquito responsible for transmitting dengue,...
3.
Lau M, Valdez A, Jones M, Aranson I, Hoffmann A, McGraw E
PLoS Negl Trop Dis
. 2024 Jul;
18(7):e0012305.
PMID: 38976758
As Wolbachia pipientis is more widely being released into field populations of Aedes aegypti for disease control, the ability to select the appropriate strain for differing environments is increasingly important....
4.
Urakova N, Joseph R, Huntsinger A, Macias V, Jones M, Sigle L, et al.
Insect Mol Biol
. 2024 Mar;
33(4):362-371.
PMID: 38450861
Multiple Wolbachia strains can block pathogen infection, replication and/or transmission in Aedes aegypti mosquitoes under both laboratory and field conditions. However, Wolbachia effects on pathogens can be highly variable across...
5.
Jones M, Uzuneser T, Clement T, Wang H, Ojima I, Rushlow W, et al.
Psychopharmacology (Berl)
. 2023 Sep;
241(1):119-138.
PMID: 37747506
Rationale: The endocannabinoid (eCB) system critically controls anxiety and fear-related behaviours. Anandamide (AEA), a prominent eCB ligand, is a hydrophobic lipid that requires chaperone proteins such as Fatty Acid Binding...
6.
Lau M, Dutra H, Jones M, McNulty B, Diaz A, Ware-Gilmore F, et al.
PLoS Negl Trop Dis
. 2023 Sep;
17(9):e0011616.
PMID: 37669272
Jamestown Canyon virus (JCV), a negative-sense arbovirus, is increasingly common in the upper Midwest of the USA. Transmitted by a range of mosquito genera, JCV's primary amplifying host is white-tailed...
7.
Novelo M, Dutra H, Metz H, Jones M, Sigle L, Frentiu F, et al.
PLoS Pathog
. 2023 Apr;
19(4):e1011307.
PMID: 37043515
Aedes aegypti is the primary vector of the arboviruses dengue (DENV) and chikungunya (CHIKV). These viruses exhibit key differences in their vector interactions, the latter moving more quicky through the...
8.
Uzuneser T, Szkudlarek H, Jones M, Nashed M, Clement T, Wang H, et al.
Cereb Cortex
. 2022 Jun;
33(6):2470-2484.
PMID: 35650684
The endocannabinoid (eCB) system represents a promising neurobiological target for novel anxiolytic pharmacotherapies. Previous clinical and preclinical evidence has revealed that genetic and/or pharmacological manipulations altering eCB signaling modulate fear...
9.
Ware-Gilmore F, Sgro C, Xi Z, Dutra H, Jones M, Shea K, et al.
PLoS Negl Trop Dis
. 2021 Jul;
15(7):e0009548.
PMID: 34292940
The mosquito Aedes aegypti is the primary vector of many disease-causing viruses, including dengue (DENV), Zika, chikungunya, and yellow fever. As consequences of climate change, we expect an increase in...
10.
Patel D, Field C, Septer K, Sim D, Jones M, Heinly T, et al.
J Virol
. 2021 Apr;
95(13):e0223220.
PMID: 33827954
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has initiated a global pandemic, and several vaccines have now received emergency use authorization. Using the reference strain SARS-CoV-2 USA-WA1/2020, we evaluated modes...